Refresh
X
Gainers
Losers
Sectors
Indices
Forex
Mutual Funds
Home
Indices
Sectors
Mutual Funds
Gainers
Losers
Forex
Investment Tool
All Pages
Aurobindo Pharma Ltd.
BSE
Price on BSE
23 Jan,15:55 LIVE
1,133.15
-12.45
(-1.09%)
© 2026 Rediff.com
Volume :
10,811.00
Prev Close :
1,145.60
Day's H/L (Rs.) :
1,150.00 - 1,122.45
52wk H/L (Rs.) :
1,278.00 - 994.35
Mkt Cap (Rs. Cr) :
65,813.36
NSE
Price on NSE
23 Jan,15:40 LIVE
1,132.50
-12.80
(-1.12%)
© 2026 Rediff.com
Volume :
511,822.00
Prev Close :
1,145.30
Day's H/L (Rs.) :
1,150.50 - 1,120.80
52wk H/L (Rs.) :
1,278.60 - 1,010.00
Mkt Cap (Rs. Cr) :
0.00
View more
Market News
USFDA's new draft biosimilar rules to benefit Indian biotech cos
Rediff.com
09 Nov 2025
Report Card - Aurobindo Pharma Ltd.
PE Ratios
37.68
EPS (Rs.)
30.08
Sales (Rs. Cr)
2,789.72
Face Value (Rs.)
1
Net Profit Margin(%)
15.97
Last Bonus
1:1
Last Dividend(%)
400
Return on Average Equity
8.5
News for Aurobindo Pharma Ltd.
Aurobindo Pharma: Health Canada Approves Dyrupeg
Aurobindo Pharma arm CuraTeQ Biologics gets Health Canada compliance for Dyrupeg biosimilar. Cancer treatment for low neutrophils.
Jan 09, 2026 16:00
Aurobindo to Acquire Stake in JV Firm
Aurobindo Pharma to acquire additional 20% stake in China-based joint venture Luoxin Aurovitas Pharma for USD 5.12 million.
Dec 23, 2025 18:46
Aurobindo Pharma Gets USFDA Form 483
USFDA issues Form 483 with 5 observations to Aurobindo Pharma's Andhra Pradesh unit. Inspection details and company response inside.
Dec 18, 2025 11:33
MIP to Counter Chinese Price Cuts: BDMA Asks Centre
Bulk drug makers urge Centre to expedite MIP implementation to combat predatory Chinese pricing. MIP is a stabilisation tool, not a trade barrier.
Dec 16, 2025 09:24
Delius Pharma to Import Ceftriaxone API from China
Delius Pharma gets CDSCO approval to import Ceftriaxone Sodium API from China. Enhances supply, ensures quality, reduces dependency.
Dec 10, 2025 16:55
More News for Aurobindo Pharma Ltd. »
News for Pharmaceuticals and health care
Renault Duster Re-launch: New Growth Phase in India
Renault re-launches Duster in India, signaling a new growth phase. CEO Fabrice Cambolive outlines plans for the Indian market.
Jan 26, 2026 21:25
Renault Duster Re-launch: India Growth Phase
Renault re-launches Duster in India, signaling a new growth phase. Focus on local manufacturing, EV tech, and global competitiveness.
Jan 26, 2026 20:17
Axis Bank Q3 Profit Up 4%, Retail Loans Grow 6%
Axis Bank reports 4% rise in Q3 net profit to Rs 7,010.65 crore. Retail loans up 6%, overall loan growth boosted by small business lending.
Jan 26, 2026 19:48
India Office Demand: Global Firms Drive Leasing in 2025
Global firms drove India''s office space demand in 2025, leasing 58% of space. GCCs are dominant. Bengaluru is preferred.
Jan 26, 2026 19:14
IIFL Finance: Home Loans to Drive Growth
IIFL Finance expects home loans to drive growth. Gold loans surged. Asset quality improves. Focus on secured lending and profitability.
Jan 26, 2026 19:10
More News »
Top News
Renault Duster Re-launch: New Growth Phase in India
Renault re-launches Duster in India, signaling a new growth phase. CEO Fabrice Cambolive outlines plans for the Indian market.
Jan 26, 2026 21:25
Renault Duster Re-launch: India Growth Phase
Renault re-launches Duster in India, signaling a new growth phase. Focus on local manufacturing, EV tech, and global competitiveness.
Jan 26, 2026 20:17
Axis Bank Q3 Profit Up 4%, Retail Loans Grow 6%
Axis Bank reports 4% rise in Q3 net profit to Rs 7,010.65 crore. Retail loans up 6%, overall loan growth boosted by small business lending.
Jan 26, 2026 19:48
India Office Demand: Global Firms Drive Leasing in 2025
Global firms drove India''s office space demand in 2025, leasing 58% of space. GCCs are dominant. Bengaluru is preferred.
Jan 26, 2026 19:14
IIFL Finance: Home Loans to Drive Growth
IIFL Finance expects home loans to drive growth. Gold loans surged. Asset quality improves. Focus on secured lending and profitability.
Jan 26, 2026 19:10
More Top News »
Sectoral Indices
Market Indicators
Listed Companies
Gainers
Losers
Mutual Funds
Portfolio
Watchlist